These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2792558)

  • 41. Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats.
    Bhandari KH; Newa M; Chapman J; Doschak MR
    J Control Release; 2012 Feb; 158(1):44-52. PubMed ID: 22001608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in bone histomorphometry and bone mineral during treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
    Lindholm TS; Nilsson OS; Elmstedt E; Eriksson SA; Lindholm TC; Kyhle BR
    Acta Vitaminol Enzymol; 1981; 3(3):170-6. PubMed ID: 7347489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current treatment options for osteoporosis.
    Adachi JD
    J Rheumatol Suppl; 1996 Aug; 45():11-4. PubMed ID: 8856645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of osteoporosis (with the exception of hormone replacement and its derivates].
    Lamy O; Mischler C; Krieg MA
    Rev Med Suisse Romande; 2002 Aug; 122(8):389-93. PubMed ID: 12357732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of alendronate, calcitonin and calcium treatments in postmenopausal osteoporosis.
    Dursun N; Dursun E; Yalçin S
    Int J Clin Pract; 2001 Oct; 55(8):505-9. PubMed ID: 11695068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salmon calcitonin in the therapy of corticoid-induced osteoporosis.
    Ringe JD; Welzel D
    Eur J Clin Pharmacol; 1987; 33(1):35-9. PubMed ID: 3319638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone loss and bone blood flow in paraplegic rats treated with calcitonin, diphosphonate, and indomethacin.
    Schoutens A; Verhas M; Dourov N; Bergmann P; Caulin F; Verschaeren A; Mone M; Heilporn A
    Calcif Tissue Int; 1988 Feb; 42(2):136-43. PubMed ID: 3127026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salmon calcitonin in the treatment of postmenopausal osteoporosis.
    Fatourechi V; Heath H
    Ann Intern Med; 1987 Dec; 107(6):923-5. PubMed ID: 3318613
    [No Abstract]   [Full Text] [Related]  

  • 49. [Trabecular bone microarchitecture and male osteoporosis].
    Legrand E; Chappard D; Pascaretti C; Duquenne M; Rohmer V; Basle MF; Audran M
    Morphologie; 1999 Jun; 83(261):35-40. PubMed ID: 10546234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of osteoporosis with calcitonin, with and without growth hormone.
    Aloia JF; Vaswani A; Kapoor A; Yeh JK; Cohn SH
    Metabolism; 1985 Feb; 34(2):124-9. PubMed ID: 3969014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Behavior of urinary excretion of cyclic AMP in post-menopausal osteoporosis during therapy with salmon calcitonin].
    Nuti R; Galli M; Righi GA; Turchetti V; Campagna MS; Franci B
    Minerva Med; 1982 May; 73(19):1283-9. PubMed ID: 6281691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The treatment of osteoporosis. Antiresorptive therapy.
    Miller PD
    Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of the effects of anabolic steroids, calcitonin and 25-hydroxycholecalciferol on the spongy bone of rats].
    Carrozzo M; Cantatore FP; Pallante R; Lo Sasso F; D'Amore M; Pipitone V
    Rev Rhum Mal Osteoartic; 1985 Jan; 52(1):17-9. PubMed ID: 3992151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-osteopenic effect of nasal salmon calcitonin in type 1 osteoporotic rats: comparison with subcutaneous dosing.
    Ichikawa M; Nakamuta H; Hoshino T; Ogawa Y; Koida M
    Biol Pharm Bull; 1994 Jul; 17(7):911-3. PubMed ID: 8000375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term treatment with calcitonin in osteoporosis.
    Gennari C; Agnusdei D; Camporeale A
    Horm Metab Res; 1993 Sep; 25(9):484-5. PubMed ID: 8225202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of bone quality, quantity, and turnover with multiple methodologies at multiple skeletal sites.
    Chesnut C; Majumdar S; Gardner J; Shields A; Newitt DC; Erickson E; Glott M; Kriegman A; Mindeholm L
    Adv Exp Med Biol; 2001; 496():95-7. PubMed ID: 11783630
    [No Abstract]   [Full Text] [Related]  

  • 57. Combined treatment of post-menopausal osteoporosis: effect on muscle function and a new radiological method for assessing trabecular bone.
    Crisp AJ; Buckland-Wright JC; Kauffmann EA; Gibson T
    Curr Med Res Opin; 1984; 8(10):701-7. PubMed ID: 6723347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salmon calcitonin.
    Orr PM
    Orthop Nurs; 1993; 12(5):45-7, 70. PubMed ID: 8233579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regional bone density measurements compared to total body calcium in osteoporosis.
    Hesp R; Bydder GM; Elsasser U; Reeve J; Spinks TJ
    Metab Bone Dis Relat Res; 1982; 4(3):169-73. PubMed ID: 7154933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term calcitonin therapy in postmenopausal osteoporosis.
    Gruber HE; Ivey JL; Baylink DJ; Matthews M; Nelp WB; Sisom K; Chesnut CH
    Metabolism; 1984 Apr; 33(4):295-303. PubMed ID: 6423929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.